Department of Physiology and Pharmacology, Centre for Ophthalmology and Visual Science, Lions Eye Institute, University of Western Australia, Western Australia, Australia Aim: To examine the acute ...
Purpose To describe changes in the prevalence of visual impairment and glasses ownership with age and as associated with income and population density for visual impairment among rural and urban ...
Background To investigate prevalence and risk factors of epiretinal membrane (ERM), particularly those associated with ERM ...
Background/aims To estimate 2015 global ophthalmologist data and analyse their relationship to income groups, prevalence rates of blindness and visual impairment and gross domestic product (GDP) per ...
Correspondence to Dr Jean-Jacques Gicquel, Department of Ophthalmology, CHU Jean Bernard, 86021 Poitiers Cedex, France; j.j.gicquel{at}chu-poitiers.fr Acid burns (pH<4): strong acids such as sulfuric ...
Background/aim To assess the coverage of cataract surgery services and the outcomes of surgeries including the causes of poor ...
Objective To correlate the intraoperative endoscopic findings with high-resolution CT (HRCT) for the diagnosis of optic canal fractures (OCF). To compare the visual outcome of patients with different ...
Aims To investigate the interaction and combined effects of cardiovascular health (CVH) and socioeconomic status (SES) on ...
Correspondence to: Dr Daniel Mojon Department of Ophthalmology, Kantonsspital, 9007 St. Gallen, Switzerland; daniel.mojon{at}kssg.ch Aims: To assess waiting times for cataract surgery and their ...
Correspondence to Dr Tae-Young Chung, Ophthalmology, Samsung Medical Center, Seoul, Gangnam-gu, Korea (the Republic of); tychung{at}skku.edu Background Corneal nerve damage after laser epithelial ...
Correspondence to Dr Yasmine El Sayed, Department of Ophthalmology, Kasr Al Ainy Faculty of Medicine, Cairo University, Cairo 12311, Egypt; Yasminemelsayed{at}yahoo.com Methods Multivariate linear ...
Background: Bimatoprost 0.03% has been shown to consistently reduce mean intraocular pressure (IOP) more than timolol 0.5% over 2 years. To further evaluate long-term safety and efficacy, once-daily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results